Bartlett & Co. Wealth Management LLC Bristol Myers Squibb CO Transaction History

Bartlett & Co. Wealth Management LLC

$6.97 Trillion
Q3 2024

A detailed history of Bartlett & Co. Wealth Management LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Bartlett & Co. Wealth Management LLC holds 172,563 shares of BMY stock, worth $9.97 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares

172,563

Previous 190,711 9.52%

Holding current value

$9.97 Million

Previous $7.92 Billion 12.73%

% of portfolio

0.13%

Previous 0.12%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 17, 2024	SELL	$39.66 - $51.75 $719,749 - $939,159	-18,148 Reduced 9.52%	172,563 $8.93 Billion
Q2 2024 Jul 12, 2024	SELL	$40.25 - $52.99 $1.3 Million - $1.71 Million	-32,232 Reduced 14.46%	190,711 $7.92 Billion
Q1 2024 May 09, 2024	SELL	$47.98 - $54.4 $2.76 Million - $3.13 Million	-57,567 Reduced 20.52%	222,943 $12.1 Billion
Q4 2023 Feb 14, 2024	SELL	$48.48 - $57.85 $4.81 Million - $5.74 Million	-99,303 Reduced 26.15%	280,510 $14.4 Billion
Q3 2023 Feb 14, 2024	SELL	$57.89 - $64.73 $12.2 Million - $13.6 Million	-210,231 Reduced 35.63%	379,813 $22 Billion
Q2 2023 Feb 14, 2024	SELL	$63.71 - $70.74 $17.2 Million - $19.1 Million	-270,369 Reduced 31.42%	590,044 $37.7 Billion
Q1 2023 Feb 14, 2024	BUY	$65.71 - $74.53 $465,358 - $527,821	7,082 Added 0.83%	860,413 $59.6 Billion
Q4 2022 Feb 14, 2024	BUY	$68.48 - $81.09 $205,713 - $243,594	3,004 Added 0.35%	853,331 $61.4 Billion
Q3 2022 Feb 14, 2024	BUY	$0.13 - $76.84 $759 - $448,668	5,839 Added 0.69%	850,327 $60.5 Billion
Q2 2022 Feb 14, 2024	SELL	$72.62 - $79.98 $812,617 - $894,976	-11,190 Reduced 1.31%	844,488 $65.5 Billion
Q1 2022 Feb 14, 2024	BUY	$61.48 - $73.72 $1.49 Million - $1.79 Million	24,291 Added 2.92%	855,678 $63 Billion
Q4 2021 Feb 14, 2024	SELL	$53.63 - $62.52 $2.65 Million - $3.09 Million	-49,373 Reduced 5.61%	831,387 $51.8 Billion
Q3 2021 Feb 13, 2024	BUY	$59.17 - $69.31 $811,575 - $950,655	13,716 Added 1.58%	880,760 $52.5 Billion
Q2 2021 Feb 13, 2024	BUY	$61.91 - $67.42 $167,961 - $182,910	2,713 Added 0.31%	867,044 $57.9 Billion
Q1 2021 Feb 13, 2024	BUY	$59.34 - $66.74 $2.21 Million - $2.49 Million	37,236 Added 4.5%	864,331 $55 Billion
Q4 2020 Feb 13, 2024	BUY	$57.74 - $65.43 $102,315 - $115,941	1,772 Added 0.21%	827,095 $51.7 Billion
Q3 2020 Feb 13, 2024	BUY	$57.43 - $63.64 $2.28 Million - $2.53 Million	39,679 Added 5.05%	825,323 $49.8 Billion
Q2 2020 Feb 13, 2024	BUY	$54.82 - $64.09 $3.23 Million - $3.78 Million	59,007 Added 8.12%	785,644 $46.2 Billion
Q1 2020 Feb 13, 2024	BUY	$46.4 - $67.43 $1.44 Million - $2.09 Million	30,991 Added 4.45%	726,637 $40.5 Billion
Q4 2019 Feb 13, 2024	BUY	$49.21 - $64.19 $1.44 Million - $1.87 Million	29,200 Added 4.38%	695,646 $44.7 Billion
Q3 2019 Feb 13, 2024	BUY	$42.77 - $50.71 $7.19 Million - $8.53 Million	168,185 Added 33.75%	666,446 $33.8 Billion
Q2 2019 Feb 13, 2024	BUY	$44.62 - $49.34 $6,157 - $6,808	138 Added 0.03%	498,261 $22.6 Billion
Q1 2019 Feb 13, 2024	BUY	$45.12 - $53.8 $2.64 Million - $3.15 Million	58,482 Added 13.3%	498,123 $23.8 Billion
Q4 2018 Feb 13, 2024	SELL	$48.76 - $63.23 $2.33 Million - $3.03 Million	-47,862 Reduced 9.82%	439,641 $22.9 Billion
Q3 2018 Feb 13, 2024	BUY	$55.19 - $62.25 $44,041 - $49,675	798 Added 0.16%	487,503 $30.3 Billion
Q2 2018 Feb 13, 2024	SELL	$50.53 - $62.98 $2.19 Million - $2.73 Million	-43,319 Reduced 8.17%	486,705 $26.9 Billion
Q1 2018 Feb 13, 2024	BUY	$59.92 - $68.98 $31.8 Million - $36.6 Million	530,024 New	530,024 $33.5 Billion

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bartlett & Co. Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bartlett & Co. Wealth Management LLC with notifications on news.

Account

Bartlett & Co. Wealth Management LLC Bristol Myers Squibb CO Transaction History